Landscape of MET activating alterations (METa) in advanced cancers (AC) using circulating tumor DNA (ctDNA) next-generation sequencing (NGS) in Asia and the Middle East (AME)

被引：0
|
作者：
Cho, B. C. [1 ]
Peled, N. [2 ]
Ahn, B-c. [3 ]
Dawood, S. [4 ]
Tsai, C-m [5 ]
Khandelwal, S. [6 ]
Sandhir, N. [6 ]
Olsen, S. [6 ]
机构：
[1] Yonsei Univ, Med Oncol Dept 501, ABMRC, Seoul, South Korea
[2] Shaare Zedek Med Ctr, Canc Ctr, Jerusalem, Israel
[3] NCC Natl Canc Ctr, Med Oncol Dept, Goyang, South Korea
[4] Mediclin City Hosp, Oncol Dept, Dubai, U Arab Emirates
[5] Taipei Vet Gen Hosp, Oncol Dept, Taipei, Taiwan
[6] Guardant Hlth Pte Ltd, Med & Clin Affairs Dept, Singapore, Singapore
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
494P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Mobocertinib efficacy in patients with NSCLC and EGFR exon 20 insertion mutations (ex20ins) identified by next-generation sequencing (NGS) of circulating tumor DNA (ctDNA)
    Neal, Joel W.
    Li, Ying
    Yu, Ziji
    Fram, Robert J.
    Danes, Christopher
    Vincent, Sylvie
    Piotrowska, Zofia
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Liquid biopsy in the clinic prospective study of plasma circulating tumor DNA (ctDNA) next generation sequencing (NGS) in patients with advanced non-small cell lung cancers to match targeted therapy.
    Sabari, Joshua K.
    Ni, Ai
    Lee, Adrian
    Pavlakis, Nick
    Clarke, Stephen John
    Tandon, Nidhi
    Datta, Sutirtha
    DuBoff, Mariel A.
    Martinez, Andres
    Offin, Michael D.
    Isbell, James M.
    Rusch, Valerie W.
    Jones, David Randolph
    Henderson, Samantha
    Lim, Lee
    Raymond, Chris
    Li, Mark
    Riely, Gregory J.
    Rudin, Charles M.
    Li, Bob T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] Correlation of measurements of tumor heterogeneity based on next-generation sequencing (NGS) of circulating tumor DNA (ctDNA) with clinical outcomes in STEAM, a prospective, randomized, multicenter study in metastatic colorectal cancer (mCRC).
    Yaung, Stephanie
    Tikoo, Nalin
    Nicholas, Alan
    Sommer, Nicolas
    Bendell, Johanna C.
    Hurwitz, Herbert
    Price, Richard
    Palma, John F.
    Lee, John J.
    Casey, Fergal
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Concordance of mutations identified using circulating tumor DNA (ctDNA) compared to tissue based next generation sequencing (NGS) in gastrointestinal malignancies: A single institution experience.
    Kamath, Suneel Deepak
    Kalyan, Aparna
    Taxter, Timothy J.
    Wehbe, Firas
    Kircher, Sheetal Mehta
    Nimeiri, Halla Sayed
    Mulcahy, Mary Frances
    Benson, Al Bowen
    Cristofanilli, Massimo
    Giles, Francis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Analytical and clinical validation of a next-generation sequencing-based circulating tumor DNA (ctDNA) assay assures its clinical application
    Liu, W.
    Mu, S.
    Yao, J.
    Chen, H.
    Hu, Z.
    Hu, J.
    Chirn, G.
    Kang, H.
    Wang, K.
    Yao, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
    Chae, Young Kwang
    Davis, Andrew A.
    Carneiro, Benedito A.
    Chandra, Sunandana
    Mohindra, Nisha
    Kalyan, Aparna
    Kaplan, Jason
    Matsangou, Maria
    Pai, Sachin
    Costa, Ricardo
    Jovanovic, Borko
    Cristofanilli, Massimo
    Platanias, Leonidas C.
    Giles, Francis J.
    ONCOTARGET, 2016, 7 (40) : 65364 - 65373
  • [47] The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer
    Cai, Jun
    Jiang, Huihui
    Li, Shuqing
    Yan, Xiaoxia
    Wang, Meng
    Li, Na
    Zhu, Cuimin
    Dong, Hui
    Wang, Dongjuan
    Xu, Yue
    Xie, Hui
    Wu, Shouxin
    Lou, Jingwei
    Zhao, Jiangman
    Li, Qingshan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [48] Feasibility of an automated data solution for Binary Alignment Map (BAM) files generated through next generation sequencing (NGS) of circulating tumor DNA (ctDNA)
    Pellizzari, L.
    Rossi, N.
    Verardo, M.
    Spizzo, R.
    Belletti, B.
    Piazza, C.
    Puglisi, F.
    Gerratana, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S1219 - S1219
  • [49] Detection of sensitizing and resistance EGFR mutations from circulating tumor DNA (ctDNA) in blood using multiplexed next-generation sequencing in patients with advanced EGFR-mutant lung adenocarcinoma
    Goldberg, Sarah B.
    Narayan, Azeet
    Carriero, Nicholas J.
    Nemati, Roxanne
    Bommakanti, Ananth
    Wurtz, Anna
    Boffa, Daniel J.
    Decker, Roy H.
    Herbst, Roy S.
    Juergensmeier, Juliane M.
    Politi, Katerina A.
    Gettinger, Scott N.
    Patel, Abhijit
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Next-generation sequencing (NGS) of tissue and cell free DNA (cfDNA) to identify somatic and germline alterations in advanced prostate cancer.
    Cheng, Michael L.
    Abida, Wassim
    Rathkopf, Dana E.
    Arcila, Maria E.
    Barron, David
    Autio, Karen A.
    Zehir, Ahmet
    Danila, Daniel Costin
    Morris, Michael J.
    Gopalan, Anuradha
    Reuter, Victor E.
    Kantoff, Philip W.
    Slovin, Susan F.
    Robson, Mark E.
    Zhang, Liying
    Mandelker, Diana
    Tsui, Dana
    Taylor, Barry S.
    Solit, David B.
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345